Results 211 to 220 of about 229,729 (307)
Reply: Validation of MELD 3.0 in 2 centers from different continents. [PDF]
Duong N +6 more
europepmc +1 more source
A Comparison of Frailty Indices in Predicting Postoperative Outcomes After Endoscopic Sinus Surgery
ABSTRACT Objective To compare the discriminatory performance of the Risk Analysis Index (RAI) and modified Frailty Index‐5 (mFI‐5) in predicting postoperative outcomes following endoscopic sinus surgery (ESS). Study Design Retrospective cohort study. Methods Adult ESS patients were identified from the ACS‐NSQIP database (2005–2020).
Akshay Warrier +6 more
wiley +1 more source
Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. [PDF]
Nishioka C +25 more
europepmc +1 more source
North American Delphi Consensus Study on Sinonasal Malignancy Survivorship Care
ABSTRACT Background Survival for patients with sinonasal cancers has improved over the past decades, but there are no dedicated survivorship guidelines for this cohort. Objective To understand experts’ priorities and perspectives on key survivorship tenets (surveillance, second tumor screening, toxicity, and symptom management).
Matheus Sewastjanow‐Silva +18 more
wiley +1 more source
Linerixibat reduces cholestatic pruritus in patients with primary biliary cholangitis. [PDF]
Kanda T +3 more
europepmc +1 more source
ABSTRACT Background Olfactory neuroblastoma (ONB) exhibits variable recurrence patterns, with significant late recurrences occurring years after treatment. We investigated cutoff periods to define late recurrence and identified predictors that distinguish patients at risk of late recurrence from those considered cured.
Alexandria Harris +23 more
wiley +1 more source
Hepatitis D in the Middle East: A Review of Disease Burden, Health-System Barriers, and Strategic Directions for Management and Elimination. [PDF]
Alkhatry M +12 more
europepmc +1 more source

